|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-1-24
|
|
pubmed:abstractText |
In a previous paper we described 2 patients treated with a sequential biologic therapy for chronic plaque psoriasis. We used infliximab as an induction treatment followed by efalizumab. We extended this approach to 3 other patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9832
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2008 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
216
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
171-2
|
|
pubmed:meshHeading |
pubmed-meshheading:18216482-Adult,
pubmed-meshheading:18216482-Antibodies, Monoclonal,
pubmed-meshheading:18216482-Cell Migration Inhibition,
pubmed-meshheading:18216482-Dermatologic Agents,
pubmed-meshheading:18216482-Disease Progression,
pubmed-meshheading:18216482-Follow-Up Studies,
pubmed-meshheading:18216482-Humans,
pubmed-meshheading:18216482-Male,
pubmed-meshheading:18216482-Middle Aged,
pubmed-meshheading:18216482-Psoriasis,
pubmed-meshheading:18216482-Time Factors,
pubmed-meshheading:18216482-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Infliximab then efalizumab, the 'hit and run' approach does not work.
|
|
pubmed:affiliation |
Clinique et Policlinique de Dermatologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland. caroline.barde@hcuge.ch
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
